BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4540495)

  • 1. Sensitivity of Trichomonas vaginalis to chemotherapeutic agents.
    Paredes FR; Hawkins DF
    J Obstet Gynaecol Br Commonw; 1973 Jan; 80(1):86-8. PubMed ID: 4540495
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the velocity of action of trichomonocidal drugs].
    Broccali G; De Carneri I
    Ginecol Obstet Mex; 1971 Nov; 30(181):481-90. PubMed ID: 5316160
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of in-vivo resistance of trichomonas vaginalis to nitrimidazine.
    Benazet F; Guillaume L
    Lancet; 1971 Oct; 2(7731):982-3. PubMed ID: 4107939
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis.
    Chen MY; Smith NA; Fox EF; Bingham JS; Barlow D
    Int J STD AIDS; 1999 Apr; 10(4):277-80. PubMed ID: 12035784
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro sensitivity of 50 Trichomonas vaginalis strains to CP 12 574].
    Kremer M; Miltgen F; Dellenbach P
    Rev Fr Gynecol Obstet; 1972 Nov; 67(11):655-7. PubMed ID: 4540771
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
    Soffar SA; Metwali DM; Abdel-Aziz SS; el-Wakil HS; Saad GA
    J Egypt Soc Parasitol; 2001 Dec; 31(3):893-904 + 1p plate. PubMed ID: 11775115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of normal human serum on the determination of trichomonicidal drug concentrations.
    Forsgren A
    Br J Vener Dis; 1972 Jun; 48(3):205-6. PubMed ID: 4538396
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application of a method of intraperitoneal infestation of the mouse, by Trichomonas vaginalis, for the pharmacologic study of trichomonacides].
    Cavier R; Gobert JG; Savel J
    Ann Pharm Fr; 1972 Sep; 30(9):637-42. PubMed ID: 4541136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the action of nitrimidazine (nimorazol), a new systemic trichomonacidal agent. I. Microbiological study].
    De Carneri I; Cantone A; Emanueli A; Giraldi PN; Logemann W; Longo R; Meinardi G; Monti G; Nannini G; Tosolini G; Trane F; Vita G
    Boll Chim Farm; 1972 Jul; 111(7):393-408. PubMed ID: 4538708
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiparasitic nitroimidazoles. 1. Some 2-styryl-5-nitroimidazoles.
    Ross WJ; Jamieson WB; McCowen MC
    J Med Chem; 1972 Oct; 15(10):1035-40. PubMed ID: 4341747
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents.
    Lövgren T; Salmela I
    Acta Pathol Microbiol Scand B; 1978 Jun; 86B(3):155-8. PubMed ID: 102108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis.
    Walker PP; Hall RE; Wilson JD
    Int J STD AIDS; 1997 Jul; 8(7):473. PubMed ID: 9228600
    [No Abstract]   [Full Text] [Related]  

  • 15. Flunidazole--a new drug for systemic treatment of urogenital trichomoniasis.
    Pereyra AJ; Nelson RM; Ludders DJ
    Am J Obstet Gynecol; 1972 Apr; 112(7):963-6. PubMed ID: 4557646
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on antiprotozoans. 3. Isolation, identification and quantitative determination in humans of the metabolites of a new trichomonacidal agent.
    Giraldi PN; Tosolini GP; Dradi E; Nannini G; Longo R; Meinardi G; Monti G; de Carneri I
    Biochem Pharmacol; 1971 Feb; 20(2):339-49. PubMed ID: 5317098
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of trichomonas infections with tinidazol in women].
    Diwald J
    Wien Med Wochenschr; 1971 Jun; 121(24):492-4. PubMed ID: 5315293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.